Rise in demand for pet insurance, surge in prevalence of animal diseases, and increase in ownership of companion animals drive the growth of the global animal vaccines market.
Rise in demand for pet insurance, surge in prevalence of animal diseases, and increase in ownership of companion animals drive the growth of the global animal vaccines market. Veterinary organizations across the world recommended restricting animal patient care to severely ill animals and emergencies.
Global Animal Vaccines Market generated $9.09 billion in 2020, and is estimated to reach $13.78 billion by 2028, manifesting a CAGR of 5.3% from 2021 to 2028. The report offers an extensive analysis of changing market trends, major segments, top investment pockets, value chain, and competitive landscape.
Rise in demand for pet insurance, surge in prevalence of animal diseases, and increase in ownership of companion animals drive the growth of the global animal vaccines market. However, competitive prices of meat and milk along with adverse impact of veterinary vaccines on human and animal health hinder the market growth. On the other hand, surge in animal health expenditure and advancements in vaccine products present new opportunities in the coming years.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/1988
Covid-19 Scenario:
- Veterinary organizations across the world recommended restricting animal patient care to severely ill animals and emergencies. In addition, lockdown in various countries led to postponement of annual checkups, various exams, and vaccination procedures.
- Many key players ensured that the proper supply of animal vaccines is maintained as many governmental institutions worldwide have been taking stringent measures to prevent the spread of zoonotic viruses.
Based on type, the attenuated vaccines segment contributed to the largest market share, accounting for more than one-third of the total share in 2020, and is expected to continue its lead position during the forecast period. However, the DNA vaccines segment is projected to portray the highest CAGR of 8.2% from 2021 to 2028.
Based on animal type, the livestock animal segment held the largest share in 2020, accounting for nearly two-thirds of the global animal vaccines market, and is estimated to maintain its leadership status throughout the forecast period. However, the companion animal segment is expected to witness the highest CAGR of 5.6% from 2021 to 2028.
Based on region, North America accounted for the highest market share in 2020, contributing to more than one-third of the total share, and is expected to maintain its dominant share in terms of revenue by 2028. However, Asia-Pacific is projected to register the largest CAGR of 5.9% during the forecast period.
Leading players of the market-
- Merck & Co., Inc.,
- Ceva Santé Animale,
- Zoetis Inc.,
- Romvac,
- Sanofi S.A.,
- Biovac,
- Vaxxinova,
- Boehringer Ingelheim GmbH,
- Merial,
- Anicon Labor GmbH.
Trending Reports of Healthcare:
Rapid Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Wound Retractor Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch (dot) com